Cargando…
Noninvasive predictors of clinically significant portal hypertension in NASH cirrhosis: Validation of ANTICIPATE models and development of a lab‐based model
Clinically significant portal hypertension (CSPH), defined as hepatic venous pressure gradient (HVPG) ≥ 10 mm Hg, identifies patients with compensated cirrhosis at a high risk of decompensation. However, HVPG is an invasive and nuanced method. The ANTICIPATE models, which include liver stiffness mea...
Autores principales: | Rabiee, Anahita, Deng, Yanhong, Ciarleglio, Maria, Chan, Jean L., Pons, Monica, Genesca, Joan, Garcia‐Tsao, Guadalupe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701481/ https://www.ncbi.nlm.nih.gov/pubmed/36214066 http://dx.doi.org/10.1002/hep4.2091 |
Ejemplares similares
-
Sleep Disturbance Is Associated With the Presence of Portosystemic Collaterals in Patients With Compensated Cirrhosis
por: Balakrishnan, Maya, et al.
Publicado: (2021) -
Restoration of liver sinusoidal cell phenotypes by statins improves portal hypertension and histology in rats with NASH
por: Bravo, Miren, et al.
Publicado: (2019) -
Medications for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated cirrhosis
por: Rabiee, Anahita, et al.
Publicado: (2023) -
Noninvasive Diagnosis of NAFLD and NASH
por: Piazzolla, Valeria Annarita, et al.
Publicado: (2020) -
Extrahepatic Surgery in Cirrhosis Significantly Increases Portal Pressure in Preclinical Animal Models
por: Chang, Johannes, et al.
Publicado: (2021)